S. Y. Jung, M. Rosenzweig, S. M. Sereika, F. Linkov, A. Brufsky et al., Factors associated with mortality after breast cancer metastasis. Cancer Causes Control, vol.23, pp.103-115, 2012.

S. Abuzallouf, M. Motawy, and Z. Thotathil, Baseline staging of newly diagnosed breast Cancer -Kuwait Cancer control center experience, Med Princ Pract, vol.16, issue.1, pp.22-26, 2007.

F. Schuetz, I. J. Diel, M. Pueschel, V. Holst, T. Solomayer et al., Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy, Am J Obstet Gynecol, vol.196, issue.4, pp.342-343, 2007.

H. Kennecke, R. Yerushalmi, R. Woods, M. Cheang, D. Voduc et al., Metastatic behavior of breast Cancer subtypes, J Clin Oncol, vol.28, issue.20, pp.3271-3278, 2010.

K. Pogoda, A. Niwi?ska, M. Murawska, and T. Pie?kowski, Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients, Med Oncol, vol.30, issue.1, pp.388-96, 2013.

A. T. Berman, A. D. Thukral, W. T. Hwang, L. J. Solin, and N. Vapiwala, Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment, Clin Breast Cancer, vol.13, pp.88-94, 2013.

P. Follana, J. Barrière, E. Chamorey, R. Largillier, B. Dadone et al., Prognostic factors in 401 elderly women with metastatic breast Cancer, Oncology, vol.86, issue.3, pp.143-51, 2014.

R. Adam, T. Aloia, J. Krissat, M. P. Bralet, P. B. Giacchetti et al., Is liver resection justified for patients with hepatic metastases from breast cancer?, Ann Surg, vol.244, pp.897-907, 2006.

R. Adam, L. Chiche, T. Aloia, D. Elias, R. Salmon et al., Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model, Ann Surg, vol.244, pp.524-559, 2006.

A. Ruiz, C. Castro-benitez, M. Sebagh, S. Giacchetti, E. Castro-santa et al., Repeat hepatectomy for breast Cancer liver metastases, Ann Surg Oncol, vol.22, issue.3, pp.1057-66, 2015.

A. Ruiz, D. A. Wicherts, M. Sebagh, S. Giacchetti, C. Castro-benitez et al., Predictive profile-nomogram for liver resection for breast Cancer metastases: an aggressive approach with promising results, Ann Surg Oncol, vol.24, pp.535-580, 2017.

A. Ruiz, M. Sebagh, D. A. Wicherts, C. Castro-benitez, R. Van-hillegersberg et al., Long-term survival and cure model following liver resection for breast cancer metastases, Breast Cancer Res Treat, vol.170, issue.1, 2018.

J. M. Cejalvo, J. A. Perez-fidalgo, G. Ribas, O. Burgues, C. Mongort et al., Clinical implications of routine genomic mutation sequencing in PIK3CA/ AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer, Breast Cancer Res Treat, vol.160, pp.69-77, 2016.

N. P. Tobin, J. C. Harrell, J. Lovrot, E. Brage, S. et al., Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival, Ann Oncol, vol.26, pp.81-89, 2015.

E. Y. Lee and W. J. Muller, Oncogenes and tumor suppressor genes, Cold Spring Harb Perspect Biol, vol.2, p.3236, 2010.

D. Cosimo, S. Baselga, and J. , Phosphoinositide 3-kinase mutations in breast cancer: a "good" activating mutation? Clin Cancer Res, vol.15, pp.5017-5026, 2009.

J. Dunlap, C. Le, A. Shukla, J. Patterson, A. Presnell et al., Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma, Breast Cancer Res Treat, vol.120, pp.409-427, 2010.

M. Kandula, K. K. Chennaboina, A. R. Ys, and S. Raju, Phosphatidylinositol 3-kinase (PI3KCA) oncogene mutation analysis and gene expression profiling in primary breast cancer patients, Asian Pac J Cancer Prev, vol.14, pp.5067-72, 2013.

T. L. Yuan and L. C. Cantley, PI3K pathway alterations in cancer: variations on a theme, Oncogene, vol.27, pp.5497-510, 2008.

M. A. Allard, R. Saffroy, P. B. De-la-maisonneuve, R. L. Bosselut, N. Hamelin et al., Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?, Target Oncol, vol.10, issue.3, pp.415-436, 2015.

R. R. Singh, A. Bains, K. P. Patel, H. Rahimi, B. A. Barkoh et al., Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high-resolution melting curve analysis, J Mol Diagn, vol.14, pp.336-381, 2012.

M. Boros, D. Moncea, C. Moldovan, C. Podoleanu, R. Georgescu et al., Intratumoral heterogeneity for Ki-67 index in invasive breast carcinoma: a study on 131 consecutive cases, Appl Immunohistochem Mol Morphol, vol.25, issue.5, pp.338-378, 2017.

P. Nowell, The clonal evolution of tumor cell populations, Science, vol.194, issue.4260, pp.23-31, 1976.

L. Morandi, A. Pession, G. L. Marucci, M. P. Foschini, G. Pruneri et al., Intraepidermal cells of Paget's carcinoma of the breast can be genetically different from those of the underlying carcinoma, Hum Pathol, vol.34, issue.12, pp.1321-1351, 2003.

D. Frumkin, A. Wasserstrom, S. Itzkovitz, T. Stern, A. Harmelin et al., Cell lineage analysis of a mouse tumor, Cancer Res, vol.68, issue.14, pp.5924-5955, 2008.

M. Rijpkema, O. C. Boerman, and W. Oyen, Tumor targeting using radiolabeled antibodies for image-guided drug delivery, Curr Drug Targets, vol.16, issue.6, pp.625-658, 2015.

N. Sobhani, G. Roviello, S. P. Corona, M. Scaltriti, A. Ianza et al., The prognostic value of PI3K mutational status in breast cancer: a meta-analysis

, J Cell Biochem, vol.119, issue.6, pp.4287-92, 2018.